The United States intends to remove tariffs on pharmaceutical products originating from the United Kingdom. This proposed exemption, a component of a wider framework agreement between the two nations,
by The United States intends to remove tariffs on pharmaceutical products originating from the United Kingdom. This proposed exemption, a component of a wider framework agreement between the two nations,